angiotensin ii has been researched along with Cerebral Malaria in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caruso-Neves, C; Costa, MF; Ferreira-Dasilva, CT; Henriques, Md; Morrot, A; Padua, TA; Pinheiro, AA; Savino, W; Silva, LS; Silva-Filho, JL; Souza, MC | 1 |
| Baravian, C; Edagha, I; Gallego-Delgado, J; Rodriguez, A; Ruiz-Ortega, M; Ty, MC; Xu, W | 1 |
| Gallego-Delgado, J; Rodriguez, A; Walther, T | 1 |
3 other study(ies) available for angiotensin ii and Cerebral Malaria
| Article | Year |
|---|---|
Angiotensin II is a new component involved in splenic T lymphocyte responses during Plasmodium berghei ANKA infection.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cell Adhesion; Cell Line; Cell Movement; Cytokines; Disease Models, Animal; Inflammation Mediators; Lymphocyte Activation; Malaria; Malaria, Cerebral; Mice; Plasmodium berghei; Spleen; T-Lymphocyte Subsets | 2013 |
Angiotensin II Moderately Decreases Plasmodium Infection and Experimental Cerebral Malaria in Mice.
Topics: Angiotensin II; Animals; Disease Models, Animal; Humans; Malaria; Malaria, Cerebral; Mice; Mice, Inbred C57BL; Parasitemia; Plasmodium berghei; Vasoconstrictor Agents | 2015 |
The High Blood Pressure-Malaria Protection Hypothesis.
Topics: Africa; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Asia; Causality; Disease Resistance; Drug Evaluation, Preclinical; Endemic Diseases; Endothelium, Vascular; Humans; Hypertension; Malaria, Cerebral; Malaria, Falciparum; Mice; Models, Biological; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Prevalence; Receptor, Angiotensin, Type 2; Selection, Genetic | 2016 |